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Introduction
Physiological changes during pregnancy involve changes to
the interior of the eye and to the outer ocular surface. Among
the pathological alterations, several are related to gestational
hypertension, such as, central serous retinopathy and occlu-
sive vascular diseases, in addition to the evolution of preex-
isting pathologies. Likewise, the administration of ocular
drugs, depending on the route, may undergo adaptations,
justifying individualized decision-making. The timing of
delivery and its potential interference in this balance also
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Abstract Pregnancy is needed for the perpetuation of the human species, and it leads to
physiological adaptations of the various maternal organs and systems. The eye,
although a closed space, also undergoes some modifications, most of which are
relatively innocuous, but they may occasionally become pathological. For women,
pregnancy is a susceptibility period; however, for many obstetricians, their knowledge
of the ocular changes that occur during pregnancy tends to be limited. For this reason,
this is a important area of study as is necessary the development of guidelines to
approach those changes. Of equal importance are the knowledge of the possible
therapies for ophthalmological problems in this period and the evaluation of the mode
of delivery in particular conditions. For this article, an extensive review of the literature
was performed, and a summary of the findings is presented.
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Resumo A gravidez é necessária à perpetuação da espécie humana, levando a adaptações
fisiológicas dos diversos órgãos e sistemas maternos. O olho, apesar de uma cavidade
fechada, sofre também algumas modificações, a maioria relativamente inócuas, que
pontualmente poderão se tornar patológicas. A gravidez assume-se como um período
particular de suscetibilidade para a mulher; no entanto, muitos obstetras têm
conhecimento limitado sobre as alterações oftalmológicas na gravidez. Por conse-
guinte, impõe-se o seu estudo, bem como a elaboração de diretrizes para lidar com
essas mudanças. De igual importância são o conhecimento da eventual terapêutica
para problemas oftalmológicos neste período e a avaliação do tipo do parto em
condições particulares. Desta forma, foi efetuada uma revisão bibliográfica extensa e
apresentada uma síntese do tema.
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reveal remarkable interest. We performed an extensive
review and summarized the existing evidence on ophthal-
mology and pregnancy.
Methods
We performed various literature searches on the PubMed
database looking for articles published in English, French,
Spanish and Portuguese. We used the terms ophthalmology
and pregnancy; eye and pregnancy; ocular changes in preg-
nancy; ocular physiology and pregnancy; ocular diseases and
pregnancy; eye and birth; ocular diseases and delivery; and
eye and delivery. The inclusion criteria were studies about:
the changes in ophthalmology conditions caused by preg-
nancy, including physiological or pathological changes; the
ocular prescription in this period; and the relationship
between ocular diseases and delivery. Individual studies
were considered when they presented a new piece of infor-
mation. We excluded from our search works regarding
genetic or molecular studies.
Results
More than 1,500 articles were evaluated, and 46 fulfilled the
inclusion criteria. The information was analyzed for: the
consistency of the theoretical and experimental data, if
applied; the year of publication (which was not an exclusion
criterion); and the quality of the study.
Physiological Changes
Most ocular changes during pregnancy have hormonal,
metabolic, immunological, hematological and cardiovascu-
lar origin.1
Eyebrows/Chloasma
Increased periocular pigmentation is one of the most com-
mon physiological changes, known as melasma or
chloasma.2 Increased skin pigmentation occurs in 90% of
pregnant women, with the proportion of chloasma (“preg-
nancy mask”) variable (5–70%).3 It is usually limited to the
malar region, but it may include the eyebrows.4 They are
reversible, and decrease gradually after delivery (and are
rarely associated with thyroid disease).
Tear Film
Pregnancy conditions a modification in the physiology of the
tear film, due to hormonal changes and disruption of acinar
cells, producing dry eye syndrome.2,4
Pupil
The photopic and mesopic diameters of the pupil appear to
increase during pregnancy (not increasing wavelength aber-
rations), mainly in the third trimester. It has been postulated
that this is due to increased sympathetic activity.5
Cornea
The cornea, which acts as a barrier, may show a decrease in
sensitivity,1,2,6–8 an increase in thickness8 (minimal, due to
edema), and an increase in curvature during pregnancy,1,2,8
causing temporary refractive changes.2,9 All of these factors
maycontribute to contact lens intolerance (or the need to use
more flat lenses).4 This is common in pregnant women, even
if the lenses have been used for several years.2 This occurs
mainly in the second and third trimesters,10 and pregnancy is
considered a contraindication to ophthalmic surgery.1 Post-
partum, these physiological changes tend to reverse, usually
in thefirst twomonths, and it is advised to only consider lens
upgrade or refractive surgery after this period.2,4,9
Lens
A transient loss of accommodation may occur during preg-
nancy and lactation,4 and any potential surgery should be
postponed until stable refraction is achieved (if the pregnan-
cy is anticipated).2
Iris
A Krukenberg spindle (pigment deposit on the posterior
cornea) can be observed in pregnant women (3%).3 This
appears to decrease in size during the third trimester until
the postpartum period,4 mainly due to hormonal changes
and aqueous humor dynamics.4
Intraocular Pressure
It is accepted that there is a decrease in intraocular pressure
(IOP) in the second half of pregnancy,1,11 mainly in the third
trimester,1,2with a decrease in its diurnal variation compared
with pre-pregnancy values4 (probably due to an increase in
uveoscleral drainage and hormonal changes, decreasing the
aqueous humor production).1,3 It varies in adults, being lower
in the sitting position and higher in the supine position, with
an inverse variation in ocular perfusion pressure.12 There is an
improvement in preexisting glaucoma, with glaucomatous
symptomsduring gestation rarelyoccurring. The IOP regresses
to baseline values about two months postpartum.1 Applana-
tion tonometry or alternative methods such as Tono-pen
(Reichert Technologies, Depew, NY, US) and iCare (ICare
Finland Oy, Vantaa, Finland) are all valid diagnostic tools in
pregnancy.3 Dynamic tonometry has already been suggested
by some authors as a diagnostic test for pregnancy.4
Choroid
The choroidal thickness seems to be higher in pregnant
women,13–16 mainly in the first trimester,17 with the excep-
tion of preeclampsia (PE) (equal or slightly higher than non-
pregnant women).14,16 The macula appears to be
unchanged.15
Visual Field
There are visual field changes reported in pregnancy, but
their etiology is unknown.2 There is a physiological increase
of the pituitary gland, but this is insufficient by itself to cause
a defect in the visual field, unless it is accompanied by an
abnormal relationship between the optic chiasm and the
pituitary gland.4 These asymptomatic changes are complete-
ly reversible postpartum.2 If symptomatic, the existence of
masked tumors should be investigated.4
Rev Bras Ginecol Obstet Vol. 40 No. 1/2018
Ocular Changes During Pregnancy Marcos-Figueiredo et al. 33
Hemeralopia
Hemeralopia (difficulty to see in bright light; daytime blind-
ness) may also be more frequent in this period. Both the
modification of the tear film and the hemeralopia may also
be due tovitamin Adeficiency, but supplementation does not
prevent all cases, and this is controversial in pregnancy.
Postpartum
Conjunctival hemorrhage (hyposphagma) is present in 10%
of pregnant and postpartumwomen. The only recommended
intervention is monitoring the blood pressure, because it
normally resolves spontaneously.3 In ►Table 1, we summa-
rize the ocular physiological changes during pregnancy.
Pathological Changes
Pregnancy-induced Hypertension
Almost all pregnant women present reactive changes in the
retinal vessels, with clearly visible changes arising only in
the context of hypertension, PE or eclampsia.3 Gestational
hypertension occurs in 5–11% of pregnancies, with 40 to
100% demonstrating variable retinopathy, but less than half
of these are symptomatic.3 Retinal changes are directly
related to the severity of the hypertension.3 In ►Table 2
we summarize the possible hypertensive ocular changes in
pregnancy.
A retinal Doppler along with an assessment of the symp-
toms in a clinical examination demonstrated a pulsatility
index compatible with vasospasm. It occurs in 50–100% of PE
cases, is generally reversible, and followed by hemorrhages,
cotton wool spots, and, in severe cases, retinal edema and
papilledema.4 A positive correlation was established among
the degree of retinopathy, the severity of PE, maternal blood
pressure and fetal mortality.4 The use of magnesium sulfate
in the prevention and treatment of seizures has been shown
to significantly decrease this index in the posterior retinal
and ciliary arteries. Observation of the ocular fundus has
been shown to be of increasing importance, seeming to even
predict the fetal prognosis.18 In cases of PE, the retinopathy
severity appears to be linked to the level of placental insuffi-
ciency and fetal growth restriction.19,20 In the hemolysis,
elevated liver enzymes, low platelet count (HELLP) syn-
drome, bilateral serous retinal detachment and vitreous
hemorrhage may also occur.21
Management
For the mother, immediate delivery is the most beneficial
treatment option; for the fetus, we must consider matu-
rity.3 If far from term and without severity criteria, the
priority is for medical control of the hypertension and
reduction in the incidence of visual abnormalities. There
are no defined criteria for the cases in which terminating
the pregnancy is recommended to protect the ocular
health of the mother. Any proposal should be individualized
and involve shared decision-making. In ►Table 3, we sum-
marize the mostly considered indications for pregnancy
termination.4
Punctate Inner Choroidopathy
Punctate inner choroidopathy is a disease of women of repro-
ductive age, and may be associated with the development of
choroidal neovascular membranes during pregnancy.22 It is
rare and challenging, and usually has spontaneous resolution
(corticosteroid therapy may be necessary in severe cases).22
Table 1 Summary of ocular physiological changes during pregnancy
Physiological changes
Physiology Considerations Trimester (þ) Prognosis
Eyebrows/ Chloasma 5–70%, increased pigmentation
(malar region/eyebrows)
Third Reversible
Tear Film Modified # Dry eye syndrome Third Reversible
Pupil " Photopic and mesopic diameter Third Reversible
Cornea # Sensitivity, " thickness (minimal),
" curvature
Contact lens intolerance Second/Third Reversible
Lens Transient loss of accommodation All Reversible
Iris 3%, Krukenberg spindle
(pigment deposit on the
posterior cornea)
First/Second Reversible
Intraocular Pressure # Intraocular pressure Third Reversible
Choroid "Choroidal thickness Exception of preeclampsia;
macula unchanged
First Reversible
Visual field Minimal changes Asymptomatic Third Reversible
Hemeralopia Difficulty to see in bright light Third Reversible
Hyposphagma 10%, conjunctival hemorrhage Monitoring of blood pressure Postpartum Reversible
Note: þ more frequent.
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Central Serous Retinopathy
Central serous retinopathy is defined as spontaneous and
localized serous detachment of the sensorineural retina in
the macula, causing symptoms of diminished or blurred
vision, central scotomas, metamorphopsia and micropsy.1,4
It mainly affects youngmen (8 to 10:1woman), but 0.008% of
pregnant women (90% of the female population affected) and
can occur in any trimester of pregnancy (it is more frequent
in the third).1,3,4 The etiology is unknown, but this diagnosis
is made by examination, and optic coherence tomography
can be considered (it does not harm the fetus).4 It usually
resolves at the end of pregnancy or postpartum,1,4 but does
result in a higher probability of recurrence outside pregnan-
cy or in a subsequent gestation.1
Occlusive Vascular Diseases
Purtscher-like retinopathy
The etiology is related to granulocyte aggregation induced by
complement and vascular occlusion. It is associated with
labor, postpartum and complications of the late stages of
pregnancy, such as PE (as well as pancreatitis and renal
failure).4 Upon fundoscopy, cotton wool spots and retinal
hemorrhage are observed.4 This tends to resolve spontane-
ously, with full recovery of vision.
Disseminated intravascular coagulation
It may occur in cases of complicated miscarriages, placental
abruption, severe preeclampsia and retained products of
conception. It is characterized by thrombus dissemination,
with the choroid being the intraocular structure involved.4
This vascular occlusion of the capillaries leads to detachment
of the retinal pigment epithelium, causing a serous detach-
ment.4 When the scenario improves, this detachment re-
solves; however, epithelial alterations may persist.4
Thrombotic thrombocytopenic purpura
It may be observed in pregnancy, with thrombus deposition
in the vessels, hemolytic anemia, thrombocytopenia, among
others. In 10% of the cases, the ocular manifestations include
retinal vascular occlusion, retinal hemorrhage, serous de-
tachment and optic disc neovascularization.4 A picture simi-
lar to Purtscher-like retinopathymayalso occur,mainly if the
optic nerve vessels are involved.4
Amniotic fluid embolism
It is a serious complication of pregnancy, with an 80%
mortality rate. It occurs during labor, delivery, or in the
immediate postpartum period. Particulate components of
amniotic fluid enter the maternal circulation, causing car-
diopulmonary failure. Retinal occlusions may occur, and the
central retinal artery may be involved.4 However, given the
general condition and prognosis, little attention is paid to the
visual prognosis.4
Table 3 Possible indications for pregnancy termination
• Progressive severe retinopathy
• Cotton wool spots in all quadrants, with persistent
arteriolar changes
• Diabetes mellitus/renal disease causing proliferative
retinopathy with risk of visual loss
• Imminent vitreous hemorrhage
Table 2 Hypertension, pregnancy and ocular changes
Ocular symptoms1 Ocular signs1
Blurred vision Retinal arteriolar abnormalities
Decreased vision Serous retinal detachment (1% in cases of preeclampsia, 10%
in cases of eclampsia, without fetal detrimental effect)4
Flashes Ischemic optic neuropathy
Floaters Hypertensive retinopathy (if severe)
Scotomas
Visual field defects
Diplopia
Blindness (loss of vision with normal pupillary function and
ophthalmoscopic examination) is rare; it occurs in up to 15% of
the cases of preeclampsia/eclampsia, by involvement of the
occipital cortex.
#
Constitute severity criteria
May represent features of imminent seizures in cases of preeclampsia, particularly postpartum.1,4
Obstetrical assessment is imposed ) excluding preeclampsia ) ophthalmological observation.
Prognosis ) generally good (although scotomas may persist for months).
May occur only in the postpartum period, with resolution of the detachments occurring sometimes in this period.3
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Preexisting Diseases
Diabetic Retinopathy
Around 2–5% of pregnant women have preconception dia-
betes.3 Pregnancy is a major and independent risk factor for
the progression of the disease.2–4,8 There are other risk
factors known,1–3,8,23 such as the duration of the disease,2
metabolic control before and during pregnancy2,3(normo-
glycemia prior to pregnancy improves the outcome, and poor
control increases the progression, as well as a rapid normali-
zation of blood glucose levels during pregnancy,2,24 although
it is not a reason for suboptimal diabetes control in this
period),24 insulin therapy, visual acuity and macular edema
before pregnancy,3,24 the severity of the disease at concep-
tion,2,8 the coexistence of hypertension2,24 and PE,24,25 and
changes in retinal flow. Glycemic control during pregnancy is
associated with decreased risk of fetal macrosomia and
congenital malformation.26 There is also association with
increased risk of fetal loss and other obstetric complications.
In type 1 diabetesmellitus (DM), the progression seems to
be higher in the first two trimesters, with regression in the
third.24 The rate of progression seems to be identical in the
two types of previous diabetes, with type 1 more associated
with proliferative retinopathy.24 Studies suggest that reti-
nopathy does not appear to be more severe in nulliparous
than inmultiparouswomen, so the number of births does not
increase the risk of retinopathy progression.1,24 The retinop-
athy is less severe in women with two or more pregnancies.
The exactmechanismof the pathogenesis for the progression
of diabetic retinopathy (DR) during pregnancy remains
controversial.2
Retinopathy (evenwith macular edema) occurring during
the course of pregnancy has a high rate of spontaneous
regression in the third trimester or postpartum.2 This is
not so evident if the pregnant woman had a prior disease.
However, these women are at increased risk of progression
even up to one year postpartum (with vitreous hemorrhage
and retinal detachments), and ophthalmologic monitoring
should continue (even if not consensual, as they are rare
events).24 The associated visual symptoms are blurred vision,
floaters, partial or total visual loss, and they may vary and
even mimic improvement. In ►Table 4, we list the precon-
ceptional counseling and treatment for DR in this period.
The influence of pregnancy on long-term DR is still
conflicting.24 There are even fewer studies on type 2 diabe-
tes.24 With regards to gestational diabetes, there are no
similar associations with DR.1,2,8
Uveitis
Uveitis is rare, with a mean age at diagnosis of 39 years. The
impact of pregnancy on uveitis is not well-established.1,3 The
activity of the disease in the preconception period and the
existence of treatment did not influence the subsequent
activity of uveitis, which seemed to return to normal in
the puerperium.27,28 It is logical to be associated with fewer
recurrences,3 being beneficial in syndromes such as Vogt-
Koyanagi-Harada (bilateral granulomatous panuveitis,
which tends to regress during pregnancy and postpartum),4
Behcet disease and idiopathic uveitis.2 The limited evidence
available on uveitis is predominantly linked to Behcet dis-
ease. Nevertheless, women with uveitis who become preg-
nant should be advised of possible exacerbations in the first
trimester and postpartum, and there should be more careful
surveillance during these periods.1 The women who have
previously had ocular toxoplasmosis, due to the potential
risk of recurrence in pregnancy and vertical transmission,
should be followed-up in this period.29,30 The risk of congen-
ital toxoplasmosis is insignificant.4
Antiphospholipid Syndrome
Patients have a thrombophilic state and are susceptible to
arterial or venous thrombosis. Ocular manifestations may
include vascular thrombosis of the retina, choroid, and optic
nerve, as well as the oculomotor nerves.4
Ptosis
Ptosis, usually aponeurotic, presents or worsens in pregnan-
cy due to increased interstitial fluid and hormonal effects.3,4
It should be distinguished from oculomotor paralysis (with
weakness of extraocular muscles, diplopia and mydriasis),
Table 4 Preconception and therapeutic approach to diabetic retinopathy during pregnancy
Preconception – ideal
Early patient education is fundamental.
Pregnancies in the third decade (risk " exponentially with maternal age).4
Stable glucose values and treatment.4
Severe diabetic retinopathy - risk progression " – delay conception until stabilization of ocular disease.2
Treatment
Referral to an ophthalmologist is mandatory.
The treatment is the same as the one offered to non-pregnant women (except for the expectant approach,
which can be weighed until postpartum).2
Varies with disease severity at conception.4
Some guidelines (without large amounts of evidence, especially in developed countries).24
Laser or vitrectomy if needed (except in cases of macular edema).3
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which requires neurological evaluation.3 Reversible Horner
syndrome may occur after epidural analgesia, and the occur-
rence of transient facial paralysis can increase three-fold.3
Hyperemesis Gravidarum
Severe pregnancy hyperemesis may lead to Wernicke en-
cephalopathy with nystagmus and extraocular muscle pa-
ralysis, which usually improve with vitamin supplements.4
Optic neuropathy
Optic neuropathies associated with pregnancy are generally
ischemic due to thehypercoagulable state of pregnancy,which
is associated with an increased incidence of anterior ischemic
optic neuropathy. States of severe antepartum or postpartum
hemorrhage may cause posterior ischemic optic neuropathy.4
Idiopathic Cranial Hypertension
Idiopathic cranial hypertension may occur or worsen in
pregnancy due to weight gain. The only recommended
monitoring is the strict surveillance of weight gain.4
Intraocular Tumors
Pituitary adenoma
During pregnancy, the pituitary volume increases by  30%
due to an increase in the number of cells that secrete prolactin.
Similarly, a pituitary adenoma can grow and become symp-
tomatic during pregnancy. Headache, visual changes, bitem-
poral field defects and diplopia usually occur. If the pituitary
adenoma is detected during pregnancy, surveillance is usually
sufficient, unless the symptoms become worse.4 In this case,
bromocriptine, steroids and surgery may be necessary.4
Uveal melanoma
Some new cases or growth in pregnancy have been re-
ported.4 The mechanism of this growth is still uncertain,
and it does not seem to depend on hormonal factors (like the
cutaneous melanomas).1,4 The histopathology and five-year
survival rate in the few available studies are similar to those
of non-pregnant women.31
Choroidal osteoma
There have been some cases reported during pregnancy. The
etiology of exacerbation is unknown. Rapid growth during
pregnancy and subsequent postpartum regression were
documented.
Meningioma
Apreexistingmeningiomamaymanifest in the second half of
pregnancy due to increased tumor growth and vascularity,
and also probably due to hormonal changes.4
Other Diseases
Graves’ disease
Associated thyroid ophthalmopathy may present or worsen
during early pregnancy, with improvement in the third
trimester and postpartum recurrence.1
Posterior scleritis
It aggravates or recurs during pregnancy, and is treated with
oral corticosteroid therapy, although the use of a sub-Tenon
injection of triamcinolone is preferred.4
Immunological diseases
There is an improvement in the ocular and systemic mani-
festations during pregnancy of sarcoidosis, spondyloarthro-
pathies and rheumatoid arthritis, probably due to the
increase in endogenous corticosteroids in this period. Post-
partum recurrences are occasionally observed.1,4
In ►Table 5, we analyze the ocular pathological changes
during pregnancy.
Eye Medications
The corneal epithelium acts as a barrier against the penetra-
tion of topical ocular eye drops. Absorptionwill depend on the
solubility of the drug: lipophilic drugs rapidly dissolve in it.32
Eye Drops
Most medications are considered safe during pregnancy
despite the scarcity of clinical trials involving pregnant
women. Topical ocular medications have reduced the mater-
nal-fetal risk.4,33However, topical drugsmayhave a systemic
spread, possibly crossing the placenta and creating a poten-
tial risk for the fetus (as well as for a breastfeeding child).
Although it is a complexmechanism, the absorption of a part
of the eye drop through the mucosal vessels, with no first-
pass metabolism exists and it may be more problematic in
highly concentrated droplets.34
Glaucoma
Glaucoma is rare in pregnant women; however, controversy
exists when considering pharmacology in this period.3 Beta
blockers are currently recommended, and in somestudies they
are the first line treatment for pregnant women with glauco-
ma.3,35 If possible, administration in the first trimester, high
doses and starting therapy 2–3 days before delivery (to avoid
beta blockade in the newborn) should be avoided.4,32 Surgical
therapyor laser treatmentmustbeweighedagainsthighdoses
of medication.32 In►Table 636, we analyze other drugs that
can also be considered during pregnancy if beta blockers are
not effective or suitable.
Steroids
The use of topical steroids is discouraged during pregnancy,
but may be necessary for visual preservation in cases of
uveitis, and requires careful supervision.1 There are no
studies regarding this route of administration that have
proven teratogenicity in humans, perhaps due to the low
dose and ocular administration.32 Systemic corticosteroids
have a relative contraindication during pregnancy (especial-
ly at 9–12 weeks and in doses greater than 15mg/day, due to
potential risk to the palate). The topical route of administra-
tion has no known teratogenic effects.3 They can be used in
allergic conjunctivitis with antihistamines.34 Prednisone/
prednisolone crosses the placenta in a small percentage
(10 to 20%), while dexamethasone does so in its entirety.3
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Antibiotics
The use of ocular antibiotics appears to be safe. The drugs
known to be safe during pregnancy include ophthalmologi-
cal erythromycin, tobramycin and gentamicin, polymyxin B,
acyclovir and quinolones.3,4,32 Those that should be avoided
include chloramphenicol, neomycin, and tetracyclines.3,4
The successful use of chloramphenicol has been reported if
the dose and duration of the treatment have been followed
according to the prescription, and the use of this drug should
be discontinued at delivery.32
In the case of ocular toxoplasmosis, although the classic
pyrimethamine and sulfadiazine therapy has already been
usedwith serummonitoring, spiramycin is recommended as
a safe and effective alternative during pregnancy.32
Antivirals
The use of acyclovir is generally well-tolerated by pregnant
women, and it has low toxic potential and no adverse effects
described during pregnancy.32 Conjunctivitis is almost al-
ways viral, requiring no antibiotic therapy.3
Antihistamines
The use of antihistamines for allergies is considered safe;32
the anti-inflammatory medication (namely cyclosporine)
should be used on a pro re nata basis and monitored to avoid
adverse effects.32
Anti-vascular Endothelial Growth Factor
Anti-vascular endothelial growth factor (anti-VEGF) ranibi-
zumab (Lucentis, Novartis Pharma SAS, Humingue, France)
and aflibercept (Eylea, Bayer Pharma AG, Berlin, Germany)
with intravitreal administration are now approved for the
treatment of retinal vascular diseases. However, there are
few cases of reported use during pregnancy. The decision to
use is individualized, with preference to ranibizumab, since
it does not cross the placenta.3 Intravitreal bevacizumab has
already been administered in cases of high-risk pathologies,
in a small series, with a good maternal-fetal outcome.37
Analgesics/Anesthetics
No teratogenic effects havebeen reportedwith anesthetics or
topical analgesics; therefore they are considered safe to use.3
Miotics/Mydriatics
Miotics appear to be safe during pregnancy. Mydriatics, in
the amount of occasional drops for examination purposes,
are considered safe. For pupillary dilation, although sub-
stances such as tropicamide and phenylephrine are contra-
indicated during pregnancy, their use for diagnostic
purposes and in single doses seems to be consensual during
pregnancy.3 For therapeutic and longer dilatation, scopol-
amine and atropine are used locally.3
The systemic use of phenylephrine, atropine, homatro-
pine and scopolamine has been associated with minor fetal
abnormalities, such as inguinal hernia and club foot.38
The decision to usemedicationwith potential risks should
be explained and discussed with the patient. If administra-
tion is required, occlusion of the lacrimal sac (nasolacrimal
compression through medial digital pressure on the lower
eyelid and lacrimal point occlusion) must be performed to
limit the systemic absorption of themedication (►Fig. 1).4As
the opening of this point needs the eyelid open, delicate
Table 6 Drugs to consider in cases of glaucoma and pregnancy
Sympathomimetic drugs (brimonidine, clonidine, dipivefrin)
Local use may have systemic effects.3
Acetazolamide
It was associated with neonatal acidosis.
Levels can be monitored during pregnancy and puerperium (very low) – suggesting safe use.3,32,36
Reserved for lack of alternatives.3
Prostaglandins
Should be used sensibly (they may increase uterine smooth muscle tone and decrease fetal perfusion). Locally, their
concentration is low, and they are rapidly catabolized (cases of toxicity with ocular administration have not been reported).
Pilocarpine
Less studied (with effects in high doses in animals).
Reduced benefit does not justify use during pregnancy.
It should be replaced by a medical/surgical alternative.3
Fig. 1 Manual nasolacrimal occlusion after eye drop instillation.
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closure for one to two minutes can slow down the drainage.
The minimum effective dose should be used.4 More caution
will be required if systemic or topical questionable adminis-
tration is urgently needed, and the obstetrician should be
consulted.
As a general rule, all drugs should be avoided if possible in
the first trimester, due to the potential higher risk of teratoge-
nicity in this period. However, this recommendation should
not inhibit the prescription of treatments in which the mater-
nal benefit exceeds the fetal risks. Each case should be ad-
dressed individually, and, if in doubt, the possible side effects
andavailable therapeuticoptionsshouldbediscussedbetween
the patient and the clinician.32 Many drugs have not been
specifically approved for use during pregnancy and lactation,
and their use in these cases isoff-label. Consequently, informed
consent with written documentation is advisable.32
Diagnostic Agents
Fluorescein dye crosses the placenta and is present in breast
milk for at least 76 hours after administration. To date, there
are no published teratogenic effects in animals or humans.38
However, in practice, it is avoided during pregnancy unless a
threatening vision injury is diagnosed (such as in a vascular
membrane of the choroid).39–44 It should be avoided in the
first trimester and in the puerperium if the baby is undergo-
ing phototherapy (a relevant concentration in the breastmilk
is detected, with published cases of phototoxicity associated
with fluorescein).45 Indocyanine green was administered to
pregnant women with non-ophthalmologic purposes (such
as for themeasurement of the hepatic flow), without adverse
effects on the mother or fetus.38 It does not cross the
placenta, and it is unknown if it is present in the breast
milk.38 Despite the safety record, there is still widespread
hesitation about its use during pregnancy.41
Oculomotor Pathology
There are two types of oculomotor pathology: convergence
or accommodation insufficiency (which tends to occur more
in the third trimester) and oculomotor paralysis. Conver-
gence insufficiency is attributed to changes in the lens. At a
point near the eye, diplopiamay occur. Oculomotor paralysis
may occur in cases of PE due to vasospasm of the cranial
nerves,mainly the abducens and the facial nerves (and not so
much of the oculomotor nerve). Since its occurrence is rare
during routine pregnancies, PE or intracranial pathology
must be excluded.
Pregnancy and Childbirth
In theory, the efforts of labor could be rhegmatogenous
(provoking detachments of the retina by tearing) in patients
with high myopia. An ophthalmological examination is
mandatory before and during pregnancy, and the only rec-
ommendation is labor facilitated by an epidural analgesia
drug during delivery. If there are previous retinal detach-
ment lesions, a prepartum photocoagulation should be con-
sidered. It has been questionedwhether these injuries or the
existence of a previous surgery should affect the route of
delivery.42
Are there any Indications for Elective Cesarean?
Vaginal birth is almost always possible. No significant
changes in intraocular pressure during labor have been
documented.43 Cesarean section is not necessary due to
the presence of myopia, peripheral retinal degenerations
or after retinal surgery. Nevertheless, up to 2% of cases of
cesarean sections are performed because of an ophthalmo-
logic pathology (usually myopia [57%] or glaucoma [5%]).3
The recommendations regarding this mode of delivery in
women with preexisting ocular disease are not based on
evidence, even though cesarean sections are often performed
in women with ocular disease. In cases of glaucoma, the
rationale would involve increased intraocular pressure, with
a potential decrease in ocular perfusion by Valsalva maneu-
vers performed during a vaginal delivery. The absence of
ocular perfusion reduction at delivery and amodest increase
in intraocular pressure during Valsalva maneuvers, with a
mean of 4 mm Hg and a maximum of 12 mm Hg, have been
shown to be insignificant even for damaged optic nerves.3,43
For high myopic patients and women with retinal degenera-
tion or post retinal detachment, studies have shown no
association between vaginal delivery and new retinal de-
tachment/retinal degeneration regardless of current refrac-
tive error or previous vitreoretinal interventions.1,3,44 Thus,
the fear that the ophthalmological pathology will worsen
with vaginal delivery has no recognized justification for any
type of ocular pathology. Isolated preexisting ocular disease
is not an indication for cesarean section.3 In studies compar-
ing attitudes, it was concluded, in the case of women treated
for retinal detachment, that the attitude of obstetricians was
more favorable to cesarean section, while ophthalmologists
recommended spontaneous vaginal delivery. This opinion
was influenced by experience in the clinical practice.45,46
Conclusion
Pregnancy is associated with a variety of physiological ocular
changes, modifications in existing ocular pathologies and
pathological ones. Most of these resolve in the postpartum
period, and theycan rarely lead topermanentdamage invision.
In the majority of cases, either in new or preexisting
diseases, ophthalmologic therapy in this period has reduced
contraindications, withmore benefits than risks, especially if
a topical route of drug delivery is used.
Regarding delivery, even with the expulsive efforts, there
are no ophthalmological contraindications to vaginal delivery.
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